Organogenesis Holdings Inc. ( ORGO) - Stock Earnings
ORGO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
ORGO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 43.7 million USD | 225.1 million USD |
| 2026Q1 | -56.2 million USD | 37.2 million USD |
| 2026Q2 | -99.3 million USD | 43.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ORGO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.9 million USD | 433.1 million USD |
| 2024 | 861000 USD | 482.0 million USD |
| 2025 | 37.0 million USD | 563.0 million USD |
| 2026 Est. | — | — |
ORGO
Price: $1
Earnings Per Share: -0.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 317113
Market Capitalization: 171.1 million